Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by C. Galeone
MA04.07 MicroRNA-Based Liquid Biopsy Combines With PD-L1 Tumor Expression to Predict Response to Immunotherapy in Advance NSCLC Patients
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Comparison of Manual Methods of Extracting Genomic DNA From Dried Blood Spots Collected on Different Cards: Implications for Clinical Practice
International Journal of Immunopathology and Pharmacology
Allergy
Immunology
Pharmacology
Related publications
Automated Image Analysis of NSCLC Biopsies to Predict Response to Anti-Pd-L1 Therapy
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Circulating microRNAs and PD-L1 Tumor Expression Are Associated With Survival in Advanced NSCLC Patients Treated With Immunotherapy: A Prospective Study
Clinical Cancer Research
Cancer Research
Oncology
P1.04-16 Comparison of Clinical Response to Checkpoint Inhibitors in Advanced NSCLC With High PD-L1 Expression Tested on Cytology Versus Biopsy Samples
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
PD-L1 Expression and Combined Status of PD-L1/PD-1–Positive Tumor Infiltrating Mononuclear Cell Density Predict Prognosis in Glioblastoma Patients
Journal of Pathology and Translational Medicine
Forensic Medicine
Pathology
Histology
MA19.02 Prior Therapy and Increased Expression of PD-L1 in NSCLC Tumor Samples
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P1.04-11 Exploring the Germ-Line Contribution to Exceptional Response to PD-1/PD-L1 Inhibition in Patients With NSCLC by Whole Genome Sequencing
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Prognostic Impact of Tumor Cell PD-L1 Expression and Immune Cell Infiltration in NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Dynamic Metrics-Based Biomarkers to Predict Responders to Anti-Pd-1 Immunotherapy
British Journal of Cancer
Cancer Research
Oncology
MA09.09 EBUS-TBNA in Assessing PD-L1 Expression in NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary